Your browser doesn't support javascript.
loading
Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy.
Ciccimarra, Francesco; Luxi, Nicoletta; Bellitto, Chiara; L' Abbate, Luca; De Nardo, Pasquale; Savoldi, Alessia; Yeomans, Alison; Molokhia, Mariam; Tacconelli, Evelina; Trifirò, Gianluca.
Affiliation
  • Ciccimarra F; Department of Diagnostics and Public Health, Section of Pharmacology, University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy.
  • Luxi N; Department of Medicine, University of Verona, Verona, Italy.
  • Bellitto C; Department of Diagnostics and Public Health, Section of Pharmacology, University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy.
  • L' Abbate L; Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
  • De Nardo P; Infectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Savoldi A; Infectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Yeomans A; Drug Safety Research Unit, Southampton, UK.
  • Molokhia M; Department of Life Sciences and Medicine, King's College London, London, UK.
  • Tacconelli E; Infectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Trifirò G; Department of Diagnostics and Public Health, Section of Pharmacology, University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy. gianluca.trifiro@univr.it.
BioDrugs ; 37(5): 675-684, 2023 Sep.
Article in En | MEDLINE | ID: mdl-37148526
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Guideline / Risk_factors_studies Limits: Humans Language: En Journal: BioDrugs Journal subject: ALERGIA E IMUNOLOGIA / GENETICA MEDICA / TERAPEUTICA / TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article Affiliation country: Italy Country of publication: New Zealand
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Guideline / Risk_factors_studies Limits: Humans Language: En Journal: BioDrugs Journal subject: ALERGIA E IMUNOLOGIA / GENETICA MEDICA / TERAPEUTICA / TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article Affiliation country: Italy Country of publication: New Zealand